David Malka
About
David Malka is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, David Malka has authored 233 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Oncology, 112 papers in Surgery and 84 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Malka's work include Colorectal Cancer Treatments and Studies (72 papers), Pancreatic and Hepatic Oncology Research (62 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (58 papers). David Malka is often cited by papers focused on Colorectal Cancer Treatments and Studies (72 papers), Pancreatic and Hepatic Oncology Research (62 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (58 papers). David Malka collaborates with scholars based in France, United States and Germany. David Malka's co-authors include Michel Ducreux, Valérie Boige, Diane Goèré, Dominique Élias, Clarisse Dromain, Thierry de Baère, Julien Taı̈eb, Jean‐Pierre Pignon, Philippe Ruszniewski and Frédéric Dumont and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.
In The Last Decade
David Malka
220 papers receiving 9.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| David Malka France | 57 | 5.5k | 4.1k | 2.6k | 1.7k | 1.4k | 233 | 9.3k | ||
| Brian K. P. Goh Singapore | 50 | 3.4k 0.6× | 4.1k 1.0× | 2.4k 0.9× | 1.9k 1.1× | 1.5k 1.0× | 310 | 7.5k | ||
| John H. Donohue United States | 56 | 4.1k 0.7× | 5.0k 1.2× | 3.9k 1.5× | 700 0.4× | 805 0.6× | 155 | 9.2k | ||
| Charles R. Scoggins United States | 48 | 5.3k 1.0× | 3.4k 0.8× | 1.9k 0.7× | 2.6k 1.6× | 1.5k 1.1× | 278 | 8.5k | ||
| Shishir K. Maithel United States | 55 | 7.0k 1.3× | 7.0k 1.7× | 5.5k 2.2× | 1.1k 0.6× | 2.1k 1.5× | 476 | 11.8k | ||
| Johannes H.W. de Wilt Netherlands | 51 | 5.9k 1.1× | 4.2k 1.0× | 2.1k 0.8× | 1.2k 0.7× | 523 0.4× | 320 | 9.3k | ||
| Michael I. D’Angelica United States | 56 | 6.2k 1.1× | 6.9k 1.7× | 4.3k 1.7× | 2.5k 1.5× | 1.2k 0.8× | 203 | 10.7k | ||
| Valérie Boige France | 63 | 9.5k 1.7× | 5.7k 1.4× | 6.2k 2.4× | 3.9k 2.4× | 2.1k 1.5× | 287 | 17.6k | ||
| George A. Poultsides United States | 54 | 5.7k 1.0× | 4.8k 1.2× | 4.3k 1.7× | 1.2k 0.7× | 1.9k 1.4× | 397 | 10.1k | ||
| Côme Lepage France | 39 | 3.5k 0.6× | 1.8k 0.4× | 1.5k 0.6× | 988 0.6× | 943 0.7× | 214 | 5.3k | ||
| Paula Ghaneh United Kingdom | 47 | 6.0k 1.1× | 4.1k 1.0× | 1.9k 0.7× | 389 0.2× | 1.5k 1.0× | 164 | 8.0k |
Countries citing papers authored by David Malka
Since
Specialization
Citations
This map shows the geographic impact of David Malka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Malka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Malka more than expected).
Fields of papers citing papers by David Malka
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David Malka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Malka. The network helps show where David Malka may publish in the future.
Co-authorship network of co-authors of David Malka
This figure shows the co-authorship network connecting the top 25 collaborators of David Malka. A scholar is included among the top collaborators of David Malka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Malka. David Malka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Malka, David, Ivan Borbath, Andre Lopes, et al.. (2025). Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10—Precision Medicine). ESMO Open. 10(5). 104540–104540.
2.
Tzedakis, Stylianos, Alexandre Challine, Sandrine Katsahian, et al.. (2024). Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort study. European Journal of Cancer. 202. 114018–114018.
3.
Rimassa, Lorenza, Hanneke Wilmink, Judith de Vos‐Geelen, et al.. (2024). 60P Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study. Annals of Oncology. 35. S236–S236.
4.
Nicolle, Rémy, Valérie Boige, T. Pudlarz, et al.. (2023). Precision medicine for KRAS wild-type pancreatic adenocarcinomas. European Journal of Cancer. 197. 113497–113497.
5.
Edeline, Julien, Julie Henriques, Héloïse Bourien, et al.. (2023). 119P Management of biliary tract cancers in older patients: A French multicenter cohort study. Annals of Oncology. 34. S226–S227.
6.
Boilève, Alice, Étienne Rouleau, Raymond E. Eid, et al.. (2023). SO-4 Impact of molecular profiling on survival in patients with advanced biliary tract cancers. Annals of Oncology. 34. S163–S163.
7.
Delaye, Matthieu, Eric Assénat, Emmanuel Boleslawski, et al.. (2022). État des lieux des pratiques de prise en charge des cancers des voies biliaires en France : résultats de l'enquête nationale ACABi. Bulletin du Cancer. 109(11). 11S3–11S10.
8.
Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902.
9.
Vogel, Arndt, John Bridgewater, Julien Edeline, et al.. (2022). Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 34(2). 127–140.
10.
Meyer, Antoine, David Malka, Margarida Matias, et al.. (2021). Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101607–101607.
11.
Hirsch, Laure, David Malka, Simon Pernot, et al.. (2021). Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients. Cancers. 13(21). 5562–5562.
12.
McNamara, Mairéad G., Andre Lopes, Harpreet Wasan, et al.. (2020). Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer. Journal of Hepatology. 73(5). 1109–1117.
13.
Malka, David, Alexander Siebenhüner, Joachim C. Mertens, & Peter Schirmacher. (2020). The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma. SHILAP Revista de lepidopterología.
14.
Malka, David, Astrid Lièvre, Thierry André, et al.. (2020). Immune scores in colorectal cancer: Where are we?. European Journal of Cancer. 140. 105–118.
15.
Raingeaud, Joël, Joel Paulo Russomano Veiga, Laëtitia Marisa, et al.. (2019). ROCK 2 inhibition triggers the collective invasion of colorectal adenocarcinomas. The EMBO Journal. 38(14). e99299–e99299.
16.
Loriot, Marie‐Anne, Karine Le Malicot, Jean‐François Seitz, et al.. (2019). Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes. Bulletin du Cancer. 106(9). 759–775.
17.
Wislez, Marie, David Malka, Jaafar Bennouna, et al.. (2014). Nouvelle perspective de traitement dans le cancer bronchique non à petites cellules (CBNPC). Place de l’afatinib : un inhibiteur oral et irréversible de la famille ErbB. Bulletin du Cancer. 101(6). 647–652.
18.
Zaanan, Aziz, Jean–François Fléjou, Jean‐François Emile, et al.. (2011). Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy. Clinical Cancer Research. 17(23). 7470–7478.
19.
Ducreux, Michel, Valérie Boige, David Malka, & Pierre Laurent‐Puig. (2008). [Is it possible to individualize prescription of medical treatment in colorectal cancer? The clinician point of view].. PubMed. 95(10). 931–4.
20.
Malka, David, Pascal Hammel, Valérie Vilgrain, et al.. (1998). Chronic obstructive pancreatitis due to a pancreatic cyst in a patient with autosomal dominant polycystic kidney disease. Gut. 42(1). 131–134.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Brian K. P. Goh Breakdown of academic impact, for papers by John H. Donohue Breakdown of academic impact, for papers by Charles R. Scoggins Breakdown of academic impact, for papers by Shishir K. Maithel Breakdown of academic impact, for papers by Johannes H.W. de Wilt Breakdown of academic impact, for papers by Michael I. D’Angelica Breakdown of academic impact, for papers by Valérie Boige Breakdown of academic impact, for papers by George A. Poultsides Breakdown of academic impact, for papers by Côme Lepage Breakdown of academic impact, for papers by Paula Ghaneh